Zurich MG et al. |
Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. |
2005 |
Neuroscience |
pmid:15994020
|
Pena-dos-Santos DR et al. |
Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. |
2009 |
Neuroscience |
pmid:19647045
|
Liu H et al. |
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. |
2013 |
Neurotoxicology |
pmid:23973622
|
González E et al. |
Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. |
2002 |
Nitric Oxide |
pmid:11890746
|
Burgermeister E et al. |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. |
2003 |
Oncogene |
pmid:12813462
|
Kar R et al. |
A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. |
2009 |
Oncogene |
pmid:19448671
|
Kim DH et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. |
2010 |
Oncogene |
pmid:20208557
|
Crabb SJ et al. |
BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. |
2008 |
Oncol. Rep. |
pmid:18288403
|
Takashima T et al. |
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. |
2005 |
Oncol. Rep. |
pmid:15756430
|
Yen CC et al. |
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. |
2014 |
Oncotarget |
pmid:24566468
|
Yuan J et al. |
M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway. |
2017 |
Oncotarget |
pmid:28423639
|
Brummond KM et al. |
The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. |
2004 |
Org. Lett. |
pmid:14723515
|
Fahmi H et al. |
15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. |
2002 |
Osteoarthr. Cartil. |
pmid:12435328
|
Masamune A et al. |
Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. |
2002 |
Pancreas |
pmid:11854617
|
Hashimoto K et al. |
Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. |
2004 |
Pancreas |
pmid:15028947
|
Hashimoto K et al. |
The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. |
2003 |
Pancreas |
pmid:12826907
|
Hagens WI et al. |
Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. |
2007 |
Pharm. Res. |
pmid:17245650
|
Reyes-Martin P et al. |
Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. |
2007 |
Pharmacol. Res. |
pmid:17291778
|
Reyes-Martin P et al. |
15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. |
2008 |
Pharmacol. Res. |
pmid:18456507
|
Wung BS et al. |
Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. |
2006 |
Pharmacol. Res. |
pmid:16243536
|
Azuma Y et al. |
Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. |
2004 |
Pharmacology |
pmid:15240994
|
Lappas M et al. |
Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. |
2004 Sep-Oct |
Placenta |
pmid:15450387
|
Suwaki N et al. |
Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. |
2007 |
Placenta |
pmid:16753211
|
Fournier T et al. |
Involvement of PPARgamma in human trophoblast invasion. |
2007 |
Placenta |
pmid:17321592
|
Moore RM et al. |
Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. |
2003 Feb-Mar |
Placenta |
pmid:12566244
|
Lappas M et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. |
2006 Nov-Dec |
Placenta |
pmid:16434095
|
Lefils-Lacourtablaise J et al. |
The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism. |
2013 |
PLoS ONE |
pmid:23734181
|
Sykes L et al. |
Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes. |
2012 |
PLoS ONE |
pmid:23226366
|
Gao D et al. |
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. |
2015 |
PLoS ONE |
pmid:25874449
|
Xu F et al. |
Peroxisome proliferator-activated receptor-γ agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury. |
2013 |
PLoS ONE |
pmid:23372817
|
Wang P et al. |
Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. |
2011 |
PLoS ONE |
pmid:22096605
|
Alba G et al. |
Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils. |
2012 |
PLoS ONE |
pmid:23115616
|
Paulitschke V et al. |
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. |
2012 |
PLoS ONE |
pmid:23049949
|
Yamamoto Y et al. |
Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. |
2011 |
PLoS ONE |
pmid:21445266
|
Savinainen JR et al. |
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A). |
2014 |
PLoS ONE |
pmid:25290914
|
Samikkannu T et al. |
Immunopathogenesis of HIV infection in cocaine users: role of arachidonic acid. |
2014 |
PLoS ONE |
pmid:25171226
|
Kanakasabai S et al. |
PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. |
2012 |
PLoS ONE |
pmid:23185633
|
Buckner MM et al. |
15-Deoxy-Δ12,14-prostaglandin J2 inhibits macrophage colonization by Salmonella enterica serovar Typhimurium. |
2013 |
PLoS ONE |
pmid:23922794
|
Liu L et al. |
Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. |
2013 |
PLoS ONE |
pmid:24023668
|
Sharvit E et al. |
Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists. |
2013 |
PLoS ONE |
pmid:24098526
|
Kim KR et al. |
15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. |
2015 |
PLoS ONE |
pmid:25859665
|
Seno T et al. |
15-Deoxy-Δ¹²,¹ⴠprostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. |
2011 |
PLoS ONE |
pmid:22003398
|
de Jong E et al. |
Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. |
2011 |
PLoS ONE |
pmid:21957481
|
Li H and Pauza CD |
Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells. |
2009 |
PLoS ONE |
pmid:19888466
|
Khanim FL et al. |
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. |
2009 |
PLoS ONE |
pmid:19997560
|
de Melo NF et al. |
15d-PGJ2-Loaded Solid Lipid Nanoparticles: Physicochemical Characterization and Evaluation of Pharmacological Effects on Inflammation. |
2016 |
PLoS ONE |
pmid:27575486
|
Koharudin LM et al. |
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20231490
|
Straus DS et al. |
15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. |
2000 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10781090
|
Kondo M et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12032289
|
Oliva JL et al. |
The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12684535
|